Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 9, Pages 2390
Publisher
MDPI AG
Online
2020-08-24
DOI
10.3390/cancers12092390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
- (2020) Matthias Guckenberger et al. LANCET ONCOLOGY
- CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial
- (2020) Rob Coleman et al. Trials
- Molecular imaging of bone metastases and their response to therapy
- (2020) Gary Cook et al. JOURNAL OF NUCLEAR MEDICINE
- Utilization of stereotactic ablative radiotherapy in oligometastatic & oligoprogressive skeletal metastases: Results and pattern of failure
- (2019) Tsz Yeung Kam et al. Asia-Pacific Journal of Clinical Oncology
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
- (2019) Kang Liang Zeng et al. Frontiers in Oncology
- Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: Preliminary assessment of toxicity
- (2019) Edy Ippolito et al. BREAST
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Therapeutic Irradiation: Consequences for Bone and Bone Marrow Adipose Tissue
- (2019) Samantha Costa et al. Frontiers in Endocrinology
- CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases
- (2019) Nicholas B. Figura et al. JOURNAL OF NEURO-ONCOLOGY
- Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial
- (2019) Francesco Cellini et al. Trials
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
- (2018) F Cardoso et al. ANNALS OF ONCOLOGY
- Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States
- (2018) Rohini K. Hernandez et al. BMC CANCER
- Early Tissue Effects of Stereotactic Body Radiation Therapy for Spinal Metastases
- (2018) Jasper G. Steverink et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
- (2018) Debu Tripathy et al. LANCET ONCOLOGY
- Histopathological Findings After Reirradiation Compared to First Irradiation of Spinal Bone Metastases With Stereotactic Body Radiotherapy: A Cohort Study
- (2018) Robert Foerster et al. NEUROSURGERY
- Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial
- (2018) Marco Trovo et al. RADIOTHERAPY AND ONCOLOGY
- IMproved MAnagement (IM-MA study) in cancer-related pain: the value of a joint approach by an integrated team of radiotherapist and anesthetist
- (2018) S. Manfrida et al. SUPPORTIVE CARE IN CANCER
- Response evaluation with 18F-FDG PET/CT in metastatic breast cancer patients treated with Palbociclib: first experience in clinical practice
- (2018) Silvia Taralli et al. ANNALS OF NUCLEAR MEDICINE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oligometastatic breast cancer
- (2018) Dorota Kwapisz Breast Cancer
- Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade
- (2018) Michael T. Milano et al. RADIOTHERAPY AND ONCOLOGY
- Metastatic bone disease: Pathogenesis and therapeutic options
- (2018) Stella D'Oronzo et al. Journal of Bone Oncology
- Interventional radiology in bone metastases
- (2017) J. Chiras et al. EUROPEAN JOURNAL OF CANCER CARE
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Differences in responses to X-ray exposure between osteoclast and osteoblast cells
- (2017) Jian Zhang et al. JOURNAL OF RADIATION RESEARCH
- The impact of metastasis on the mineral phase of vertebral bone tissue
- (2017) Mikhail Burke et al. Journal of the Mechanical Behavior of Biomedical Materials
- Timing of Metastasis in Breast Cancer
- (2017) Robert S. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast carcinoma subtypes show different patterns of metastatic behavior
- (2017) István Artúr Molnár et al. VIRCHOWS ARCHIV
- Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
- (2017) Paul Lesueur et al. Oncotarget
- Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
- (2017) Qi Wu et al. Oncotarget
- Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)
- (2016) Anthony C. Wong et al. CANCER
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Early dissemination seeds metastasis in breast cancer
- (2016) Hedayatollah Hosseini et al. NATURE
- Mechanism of early dissemination and metastasis in Her2+ mammary cancer
- (2016) Kathryn L. Harper et al. NATURE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Current Status of PARP Inhibitors in Ovarian Cancer
- (2016) Jennifer McLachlan et al. TUMORI
- Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
- (2016) Stephen R. Adams et al. Nature Communications
- HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo
- (2016) Jing Hou et al. Oncotarget
- STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers
- (2016) Jae-Sung Kim et al. Oncotarget
- Curing Metastatic Breast Cancer
- (2016) George W. Sledge Journal of Oncology Practice
- The Current Status of PARP Inhibitors in Ovarian Cancer
- (2016) Jennifer McLachlan et al. TUMORI JOURNAL
- Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase
- (2015) D Di Gioia et al. BRITISH JOURNAL OF CANCER
- Feasibility and Cardiac Safety of Trastuzumab Emtansine After Anthracycline-Based Chemotherapy As (neo)Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer
- (2015) Ian E. Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial
- (2015) Denise A. Yardley et al. Trials
- Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†
- (2014) M. Piccart et al. ANNALS OF ONCOLOGY
- A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease
- (2014) Robert Coleman et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
- (2014) M Li et al. ONCOGENE
- Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
- (2013) T. de Vin et al. ANNALS OF ONCOLOGY
- Radiometabolic Treatment of Bone-Metastasizing Cancer: From 186Rhenium to 223Radium
- (2013) Giuseppe Rubini et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Functional Imaging in Extrapulmonary Sarcoidosis
- (2013) Michael Soussan et al. CLINICAL NUCLEAR MEDICINE
- Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response
- (2013) Glorianne Lazaro et al. ENDOCRINE-RELATED CANCER
- A role of intracellular mono-ADP-ribosylation in cancer biology
- (2013) Emanuele S. Scarpa et al. FEBS Journal
- Can Sarcoidosis and Metastatic Bone Lesions Be Reliably Differentiated on Routine MRI?
- (2012) Sandra Leigh Moore et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Stereotactic body radiotherapy for oligometastases
- (2012) Alison C Tree et al. LANCET ONCOLOGY
- Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer
- (2012) R. J. Kimple et al. ONCOLOGIST
- Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases
- (2012) F. Alongi et al. ONCOLOGIST
- Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review
- (2012) Tadashi Kobayashi et al. Breast Cancer
- Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy
- (2011) Hui-Lin Yang et al. EUROPEAN RADIOLOGY
- Update of the International Consensus on Palliative Radiotherapy Endpoints for Future Clinical Trials in Bone Metastases
- (2011) Edward Chow et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor Xenografts
- (2010) Maria J. Sambade et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Significantly Longer Progression-Free Survival Withnab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer
- (2009) William J. Gradishar et al. JOURNAL OF CLINICAL ONCOLOGY
- Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis
- (2009) Colleen M Costelloe et al. LANCET ONCOLOGY
- The impact of trastuzumab on radiation-induced pulmonary fibrosis: results of an experimental study
- (2009) N. S. Bese et al. MEDICAL ONCOLOGY
- Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK
- (2009) Maria J. Sambade et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic factors and a scoring system for survival after radiotherapy for metastases to the spinal column
- (2008) Masashi Mizumoto et al. CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now